title: [Ozone therapy and viscosity of blood and plasma, distance of intermittent claudication and certain biochemical components in patients with diabetes type II and ischemia of the lower extremities].
abstract: Blood and plasma viscosity, total blood lipids, triglycerides, total cholesterol, free fatty acids, fibrinogen, hematocrit, and lipidogram were determined in patients with diabetes mellitus type II and coexisting symptoms of the obliterative arteriosclerosis of the lower limbs. Intermittent claudication distance has been measured parallel. The same tests have been carried out after ozone therapy. A significant improvement in the intermittent claudication and reduction in blood and plasma viscosity have been noted. There was statistically significant correlation between intermittent claudication decrease and blood viscosity reduction following ozone therapy.
authors.affiliation: Katedry i Zakładu Biofizyki.
authors.forename: B
authors.initials: B
authors.lastname: Turczyński
authors.forename: J
authors.initials: J
authors.lastname: Sroczyński
authors.forename: Z
authors.initials: Z
authors.lastname: Antoszewski
authors.forename: B
authors.initials: B
authors.lastname: Matyszczyk
authors.forename: G
authors.initials: G
authors.lastname: Krupa
authors.forename: J
authors.initials: J
authors.lastname: Młynarski
authors.forename: M
authors.initials: M
authors.lastname: Strugala
mesh_terms: D000368:Aged; D001809:Blood Viscosity / Q000187:drug effects*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood; D003925:Diabetic Angiopathies / Q000097:blood / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007383:Intermittent Claudication / Q000097:blood / Q000188:drug therapy; D007511:Ischemia / Q000097:blood / Q000188:drug therapy*; D007866:Leg / Q000098:blood supply*; D008297:Male; D008875:Middle Aged; D010126:Ozone / Q000627:therapeutic use*
chemical_list: D010126:Ozone
vernacular_title: Ozonoterapia a lepkość krwi i osocza, dystans chromania przestankowego oraz niektóre składniki biochemiczne krwi u chorych na cukrzyce typu II z choroba niedokrwienna kończyn dolnych.